NasdaqGS - Nasdaq Real Time Price USD

Generation Bio Co. (GBIO)

2.9000 -0.1100 (-3.65%)
At close: April 26 at 4:00 PM EDT
2.9500 +0.05 (+1.72%)
After hours: April 26 at 6:56 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,904.0000
5,904.0000
--
--
--
Operating Expense
144,467.0000
144,467.0000
141,182.0000
119,101.0000
81,114.0000
Operating Income
-138,563.0000
-138,563.0000
-141,182.0000
-119,101.0000
-81,114.0000
Net Non Operating Interest Income Expense
11,951.0000
11,951.0000
4,543.0000
-50.0000
591.0000
Pretax Income
-126,612.0000
-126,612.0000
-136,639.0000
-119,151.0000
-80,523.0000
Net Income Common Stockholders
-126,612.0000
-126,612.0000
-136,639.0000
-119,151.0000
-80,523.0000
Diluted NI Available to Com Stockholders
-126,612.0000
-126,612.0000
-136,639.0000
-119,151.0000
-80,523.0000
Basic EPS
-1.96
--
-2.35
-2.12
-2.95
Diluted EPS
-1.96
--
-2.35
-2.12
-2.95
Basic Average Shares
64,483.5200
--
58,114.8930
56,295.4090
27,256.4940
Diluted Average Shares
64,483.5200
--
58,114.8930
56,295.4090
27,256.4940
Total Operating Income as Reported
-138,563.0000
-138,563.0000
-141,182.0000
-119,101.0000
-81,114.0000
Total Expenses
144,467.0000
144,467.0000
141,182.0000
119,101.0000
81,114.0000
Net Income from Continuing & Discontinued Operation
-126,612.0000
-126,612.0000
-136,639.0000
-119,151.0000
-80,523.0000
Normalized Income
-126,612.0000
-126,612.0000
-136,639.0000
-119,151.0000
-80,523.0000
Interest Income
11,951.0000
11,951.0000
4,543.0000
--
--
Interest Expense
--
--
--
50.0000
--
Net Interest Income
11,951.0000
11,951.0000
4,543.0000
-50.0000
591.0000
EBIT
-138,563.0000
-138,563.0000
-141,182.0000
-119,101.0000
-81,114.0000
EBITDA
-133,300.0000
-133,300.0000
-136,052.0000
-114,569.0000
-77,682.0000
Reconciled Depreciation
5,263.0000
5,263.0000
5,130.0000
4,532.0000
3,432.0000
Net Income from Continuing Operation Net Minority Interest
-126,612.0000
-126,612.0000
-136,639.0000
-119,151.0000
-80,523.0000
Normalized EBITDA
-133,300.0000
-133,300.0000
-136,052.0000
-114,569.0000
-77,682.0000
12/31/2020 - 6/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PMVP PMV Pharmaceuticals, Inc.
1.7500
+2.34%
 
ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
 
ANNX Annexon, Inc.
4.7000
+2.40%
 
PASG Passage Bio, Inc.
1.3200
+8.20%
 
INZY Inozyme Pharma, Inc.
4.4400
+2.54%
 
LYEL Lyell Immunopharma, Inc.
2.1700
-1.36%
 
ALGS Aligos Therapeutics, Inc.
0.7820
-4.40%
 
ELEV Elevation Oncology, Inc.
3.6200
-0.69%
 
IPSC Century Therapeutics, Inc.
2.8800
-8.57%
 
TSHA Taysha Gene Therapies, Inc.
2.3900
+3.91%